Fin Pros Still Buying This +250% Runner - InvestingChannel

Fin Pros Still Buying This +250% Runner

Proprietary Data Insights

Financial Pros’ Top Cannabis Stock Searches in the Last Month

#1CGCCanopy Growth Corp68
#3CRONCronos Group31
#4SNDLSundial Growers14
#5ACBAurora Cannabis6
#ad Handpicked winning stocks from our Oracle algorith

Fin Pros Still Buying This +250% Runner

Cannabis stocks caught fire last month as US officials offered some bullish news.

Vice President Kamala Harris asked the DEA to quickly reclassify marijuana as a less dangerous substance.

Senate majority leader Chuck Schumer circulated a petition to voters to support the SAFER Banking Act.

Weeks later, we’re still seeing financial pros actively search through the sector.

Their top stock, Canopy Growth Corp. (CGC), has risen more than 250% in less than a month.

It’s one of the few cannabis companies to turn a gross profit.

But does that make it investable?

SponsoredFast moving stocks create HUGE opportunities if you know how to play them. StocksToTrade’s algorithms send active alerts on tradable stocks, many with double-digit potential. Are you ready to get daily free trade alerts? Click Here to see how.Sponsored

Canopy Growth’s Business

Based out of Canada, where marijuana consumption is legal, Canopy Growth sells cannabis and hemp-based products for medical and recreational use in accordance with local laws.

Its revenues break down along usage and geography:

  • Canadian B2B Cannabis (32% of sales) – Sells cannabis products to retail outlets in Canada
  • Canadian Medical Cannabis (20% of sales) – Products available for medical use in Canada
  • International Cannabis (13% of sales) – Cannabis and hemp-product Sales outside of Canada
  • Storz & Bickel (22% of sales) – Leading vaporization product company
  • This Works (9% of sales) – Skincare products
  • Other (4% of sales) – Other non-psychoactive products in the wellness market.

Canopy’s latest earnings marked its third consecutive quarter and trailing twelve months of gross profits. This comes on the heels of a cost-cutting initiative meant to save $160 million CAD by the middle of February. 

That led to a 60% reduction in its workforce, the closure of multiple production facilities, and a complete divestiture of the Canadian retail footprint.

Cannabis oversupply has kept prices suppressed, hurting margins.




Unlock the Power of Wall Street! Don’t miss another opportunity to potentially increase your trading profits by 55% with our FREE Oracle Algorithm trade alerts. Start receiving daily, actionable insights directly to your inbox and SMS. Why settle for average when you can trade like the pros? Click here to subscribe now and transform your trading game. Say goodbye to emotional trading and hello to success. 




Source: Stock Analysis

Canopy’s revenues fell in the last twelve months as it divested from its retail cannabis channel, which had accounted for over $36 million in sales.

Overall, the company faces structural challenges, with upsidedown gross margins and high operating costs.

However, this is an industry-wide problem.

And with a negative operating cash flow of more than $300 million annually, Canopy’s $142 million in cash on its balance sheet will only take it through about half of the year.

Afterward, we expect them to either increase debt or tender more shares.



Source: Seeking Alpha

The overall picture for the industry isn’t pretty.

None of the competitors generate cash from operations. Only Aurora Cannabis (ACB) turns a paper profit, and barely.

However, all the cannabis stocks aren’t too expensive based on the price-to-sales ratio save Cronos (CRON).



Source: Seeking Alpha

Canopy Growth and Aurora are the only ones who saw sales decliens last year. However, Canopy is the only one that expects that to continue next year.

In fact, it has the lowest CAGR over the last 5-year period.



Source: Seeking Alpha

Profit-wise, Canopy is one of the worst.

It runs the lowest gross margins, with every other margin being negative.

In fact, only Aurora Cannabis has positive net income.


Our Opinion 0/10

These stocks are not good investments. Even if regulations weren’t a problem, the companies are fundamentally flawed.

At minimum, they should be able to generate positive cash flow within their local country.

SponsoredBut as far as trades, these types of stocks can pop off at a moment’s notice. That’s what makes StocksToTrade’s algorithms so powerful. Get free daily trade alerts on high-potential stocks delivered right to your inbox. Click Here to sign up.Sponsored

Want to get content like this directly to your inbox? Then we urge you to sign up for our newsletter here

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire